Biomerica (BMRA) Net Cash Flow (2010 - 2026)

Biomerica has disclosed Net Cash Flow across 17 years of filings, most recently posting -$1.2 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$1.2 million, down 273.07% year-over-year; the trailing twelve-month figure through Feb 2026 was -$1.7 million (up 31.96% YoY), and the FY2025 annual result was -$1.8 million, up 68.2% from the prior year.
• Net Cash Flow came in at -$1.2 million for Q1 2026 at Biomerica, down from -$509000.0 in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $6.4 million in Q2 2023 to a low of -$4.2 million in Q2 2022.
• The 5-year median for Net Cash Flow is -$854000.0 (2023), against an average of -$356659.7.
• Across the five-year window, Net Cash Flow surged 833.68% in 2022 and slumped 1115.79% in 2023, its largest moves.
• Biomerica's Net Cash Flow stood at -$1.0 million in 2022, then rose by 14.6% to -$854000.0 in 2023, then climbed by 7.38% to -$791000.0 in 2024, then soared by 35.65% to -$509000.0 in 2025, then tumbled by 133.6% to -$1.2 million in 2026.
• The last three Net Cash Flow figures came in at -$1.2 million (Q1 2026), -$509000.0 (Q4 2025), and $652000.0 (Q3 2025), per Business Quant data.